A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT05170204 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05170204
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2030-06-16
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.